Congenital Cytomegalovirus: Efficacy of Antiviral Treatment

NCT02005822 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Congenital Cytomegalovirus Infection
Sensorineural Hearing Loss

Interventions

DRUG: Valganciclovir

Sponsor

Dr. Ann C.T.M. Vossen

Collaborators

[object Object]
[object Object]